BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8229142)

  • 21. [Comparison of 18F-FDG coincidence SPECT imaging and computed tomography in the initial staging and therapeutic evaluation of lymphomas].
    Qiao WL; Zhao JH; Wang C; He ZY; Wang TS; Xing Y
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):536-9. PubMed ID: 18069637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Assessment of residual mediastinal tumor in patients with Hodgkin's lymphoma using computed tomography, magnetic resonance and 67Ga scintigraphy].
    Capua A; Osti MF; Scattoni Padovan F; Sarra R; Sbarbati S; Anselmo AP; Maurizi Enrici R
    Radiol Med; 1995 Dec; 90(6):797-803. PubMed ID: 8685466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current role of gallium scan and magnetic resonance imaging in the management of mediastinal Hodgkin lymphoma.
    Gasparini MD; Balzarini L; Castellani MR; Tesoro Tess JD; Maffioli LS; Petrillo R; Ceglia E; Musumeci R; Buraggi GL
    Cancer; 1993 Jul; 72(2):577-82. PubMed ID: 8319190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of 18F-FDG Pet/CT and CT: diagnosis performance in lymphoma patient after treatment.
    Chiewvit S; Thephamongkhol K; Ubolnuch K; Pooliam J; Phongsawat N; Chiewvit P
    J Med Assoc Thai; 2014 Jan; 97(1):85-94. PubMed ID: 24701734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic impact of pretransplantation computed tomography and gallium scans in patients with Hodgkin lymphoma with poor prognosis undergoing hematopoietic stem cell transplantation.
    Escobar IG; Barrigon DC; Tamayo P; Perez-Simon JA; Mateos MV; Garcia JR; San Miguel JF
    Clin Lymphoma Myeloma; 2006 Nov; 7(3):217-25. PubMed ID: 17229338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gallium scans in the management of patients with Hodgkin's disease: a study of 101 patients.
    Salloum E; Brandt DS; Caride VJ; Cornelius E; Zelterman D; Schubert W; Mannino T; Cooper DL
    J Clin Oncol; 1997 Feb; 15(2):518-27. PubMed ID: 9053473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of imaging for the diagnosis of residual mediastinal mass in malignant lymphomas.
    Brice P; Rain JD; Frija J
    Nouv Rev Fr Hematol (1978); 1991; 33(6):531-2. PubMed ID: 1818310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 18FDG-positron emission tomography in post treatment evaluation of residual mass in Hodgkin's lymphoma: long-term results.
    Rigacci L; Castagnoli A; Dini C; Carpaneto A; Matteini M; Alterini R; Carrai V; Nassi L; Bernardi F; Pieroni C; Bosi A
    Oncol Rep; 2005 Nov; 14(5):1209-14. PubMed ID: 16211287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gallium-67 imaging in lymphoma: tricks of the trade.
    Morton KA; Jarboe J; Burke EM
    J Nucl Med Technol; 2000 Dec; 28(4):221-32. PubMed ID: 11142323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of PET using 18F-FDG in Hodgkin's disease for posttreatment evaluation.
    Guay C; Lépine M; Verreault J; Bénard F
    J Nucl Med; 2003 Aug; 44(8):1225-31. PubMed ID: 12902411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hodgkin's disease: prognostic role of gallium scintigraphy after chemotherapy.
    Brenot-Rossi I; Bouabdallah R; Di Stefano D; Bardou VJ; Stoppa AM; Camerlo J; Sauvan R; Gastaut JA; Pasquier J
    Eur J Nucl Med; 2001 Oct; 28(10):1482-8. PubMed ID: 11685490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group.
    Josting A; Franklin J; May M; Koch P; Beykirch MK; Heinz J; Rudolph C; Diehl V; Engert A
    J Clin Oncol; 2002 Jan; 20(1):221-30. PubMed ID: 11773173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum.
    Kostakoglu L; Yeh SD; Portlock C; Heelan R; Yao TJ; Niedzwiecki D; Larson SM
    J Nucl Med; 1992 Mar; 33(3):345-50. PubMed ID: 1740700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aggressive non-Hodgkin lymphoma: early prediction of outcome with 67Ga scintigraphy.
    Front D; Bar-Shalom R; Mor M; Haim N; Epelbaum R; Frenkel A; Gaitini D; Kolodny GM; Israel O
    Radiology; 2000 Jan; 214(1):253-7. PubMed ID: 10644133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of FDG-PET imaging in the management of lymphoma.
    Kostakoglu L; Leonard JP; Coleman M; Goldsmith SJ
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):115-21. PubMed ID: 16163171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Staging and monitoring of malignant lymphoma of the bone: comparison of 67Ga scintigraphy and MRI.
    Stroszczynski C; Oellinger J; Hosten N; Spahn G; Amthauer H; Ricke J; Hoffmann KT; Eichstaedt H; Ludwig WD; Felix R
    J Nucl Med; 1999 Mar; 40(3):387-93. PubMed ID: 10086700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positron emission tomography scanning in the assessment of patients with lymphoma.
    Foo SS; Mitchell PL; Berlangieri SU; Smith CL; Scott AM
    Intern Med J; 2004 Jul; 34(7):388-97. PubMed ID: 15271172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Technetium-99m depreotide imaging by single photon emission tomography/low resolution computed tomography in malignant lymphomas: comparison with gallium-67 citrate.
    Apostolopoulos DJ; Papandrianos NI; Symeonidis A; Spyridonidis T; Alexiou S; Zampakis P; Savvopoulos C; Vassilakos PJ; Matsouka P
    Ann Nucl Med; 2010 Nov; 24(9):639-47. PubMed ID: 20799079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.